annual cash & cash equivalents:
$87.93M-$81.75M(-48.18%)Summary
- As of today (July 1, 2025), SLNO annual cash & cash equivalents is $87.93 million, with the most recent change of -$81.75 million (-48.18%) on December 31, 2024.
- During the last 3 years, SLNO annual cash & cash equivalents has risen by +$66.62 million (+312.73%).
- SLNO annual cash & cash equivalents is now -48.18% below its all-time high of $169.68 million, reached on December 31, 2023.
Performance
SLNO Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$81.33M-$6.60M(-7.50%)Summary
- As of today (July 1, 2025), SLNO quarterly cash & cash equivalents is $81.33 million, with the most recent change of -$6.60 million (-7.50%) on March 31, 2025.
- Over the past year, SLNO quarterly cash & cash equivalents has increased by +$38.48 million (+89.82%).
- SLNO quarterly cash & cash equivalents is now -52.07% below its all-time high of $169.68 million, reached on December 31, 2023.
Performance
SLNO quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
SLNO Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -48.2% | +89.8% |
| 3 y3 years | +312.7% | +180.7% |
| 5 y5 years | +324.1% | +439.7% |
SLNO Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -48.2% | +502.2% | -52.1% | +932.9% |
| 5 y | 5-year | -48.2% | +502.2% | -52.1% | +932.9% |
| alltime | all time | -48.2% | +6830.0% | -52.1% | >+9999.0% |
SLNO Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $81.33M(-7.5%) |
| Dec 2024 | $87.93M(-48.2%) | $87.93M(+81.6%) |
| Sep 2024 | - | $48.41M(-15.1%) |
| Jun 2024 | - | $57.02M(+33.1%) |
| Mar 2024 | - | $42.85M(-74.7%) |
| Dec 2023 | $169.68M(+1062.0%) | $169.68M(+223.6%) |
| Sep 2023 | - | $52.44M(+170.7%) |
| Jun 2023 | - | $19.37M(+146.0%) |
| Mar 2023 | - | $7.87M(-46.1%) |
| Dec 2022 | $14.60M(-31.5%) | $14.60M(-26.1%) |
| Sep 2022 | - | $19.75M(-17.9%) |
| Jun 2022 | - | $24.07M(-16.9%) |
| Mar 2022 | - | $28.97M(+36.0%) |
| Dec 2021 | $21.30M(-56.7%) | $21.30M(-24.4%) |
| Sep 2021 | - | $28.18M(-16.1%) |
| Jun 2021 | - | $33.60M(-19.3%) |
| Mar 2021 | - | $41.61M(-15.5%) |
| Dec 2020 | $49.22M(+137.4%) | $49.22M(-12.3%) |
| Sep 2020 | - | $56.14M(-10.2%) |
| Jun 2020 | - | $62.50M(+314.7%) |
| Mar 2020 | - | $15.07M(-27.3%) |
| Dec 2019 | $20.73M | $20.73M(+84.7%) |
| Sep 2019 | - | $11.22M(-27.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2019 | - | $15.50M(-20.1%) |
| Mar 2019 | - | $19.40M(-16.0%) |
| Dec 2018 | $23.10M(+35.1%) | $23.10M(+125.6%) |
| Sep 2018 | - | $10.24M(-18.7%) |
| Jun 2018 | - | $12.59M(-15.3%) |
| Mar 2018 | - | $14.87M(-13.1%) |
| Dec 2017 | $17.10M(+527.3%) | $17.10M(+202.8%) |
| Sep 2017 | - | $5.65M(-25.2%) |
| Jun 2017 | - | $7.55M(-28.4%) |
| Mar 2017 | - | $10.54M(+286.6%) |
| Dec 2016 | $2.73M(-50.4%) | $2.73M(-49.7%) |
| Sep 2016 | - | $5.42M(+116.4%) |
| Jun 2016 | - | $2.50M(-61.5%) |
| Mar 2016 | - | $6.49M(+18.2%) |
| Dec 2015 | $5.49M(-30.9%) | $5.49M(+16.4%) |
| Sep 2015 | - | $4.72M(-37.3%) |
| Jun 2015 | - | $7.53M(-21.0%) |
| Mar 2015 | - | $9.53M(+19.8%) |
| Dec 2014 | $7.96M(+527.1%) | $7.96M(>+9900.0%) |
| Sep 2014 | - | $64.00K(-94.7%) |
| Jun 2014 | - | $1.21M(+58.1%) |
| Mar 2014 | - | $763.90K(-39.8%) |
| Dec 2013 | $1.27M(-41.1%) | $1.27M |
| Dec 2012 | $2.16M | - |
FAQ
- What is Soleno Therapeutics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Soleno Therapeutics?
- What is Soleno Therapeutics annual cash & cash equivalents year-on-year change?
- What is Soleno Therapeutics quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for Soleno Therapeutics?
- What is Soleno Therapeutics quarterly cash & cash equivalents year-on-year change?
What is Soleno Therapeutics annual cash & cash equivalents?
The current annual cash & cash equivalents of SLNO is $87.93M
What is the all time high annual cash & cash equivalents for Soleno Therapeutics?
Soleno Therapeutics all-time high annual cash & cash equivalents is $169.68M
What is Soleno Therapeutics annual cash & cash equivalents year-on-year change?
Over the past year, SLNO annual cash & cash equivalents has changed by -$81.75M (-48.18%)
What is Soleno Therapeutics quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of SLNO is $81.33M
What is the all time high quarterly cash & cash equivalents for Soleno Therapeutics?
Soleno Therapeutics all-time high quarterly cash & cash equivalents is $169.68M
What is Soleno Therapeutics quarterly cash & cash equivalents year-on-year change?
Over the past year, SLNO quarterly cash & cash equivalents has changed by +$38.48M (+89.82%)